MindBio Deploys Voice-Activated AI Solution for Mining Industry
Vancouver, British Columbia — February 4, 2026 — Leads & Copy — Following its recent success meeting with mining and health executives in South America, MindBio Therapeutics Corp. has deployed a team of software engineers to the mining industry to build a protocol for practical implementation of drug and alcohol screening by voice.
The voice analytics enterprise solution being developed by MindBio’s engineers is designed to detect intoxication in industries such as mining, aviation, and construction where high-volume testing at scale for a variety of drugs and alcohol presents challenges. The company notes current methods are time consuming, physically invasive and expensive.
CEO Justin Hanka said MindBio is seizing its first mover advantage in voice activated AI digital health diagnostics by investing heavily to develop scalable solutions for workplace health and safety related to drug and alcohol intoxication. He added the company is excited by the response it has received and looks to provide a solution to the mining industry initially in Chile and then more broadly in South America and globally.
National work force studies in Chile alone, show that alcohol consumption among mining workers exceeds 75 per cent and the proportion of problem drinkers is above 40 per cent with drug use estimated in 9 per cent of the more than 200,000 mining workers in the country (ACHS, 2012: SENDA, 2024). Internationally more than 20 to 25 per cent of all occupational accidents are directly or indirectly linked to substance use (International Labour Organization 1996, 2022: Gomez et al., 2002). This translates to tens of thousands of preventable workplace incidents related to drug and alcohol intoxication, creating a large potential market for the Company’s Al Platform.
MindBio is a biotechnology company that conducts clinical health research and has developed an AI prediction tool for drug and alcohol intoxication detection by voice. The AI prediction model uses over 50 million data points to predict alcohol intoxication with accuracy, just by using the human voice. The Company is now collecting data that will allow its prediction tool to work on other types of intoxication.
MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) is a biotechnology company headquartered in Vancouver, British Columbia, that for several years has been conducting drug and alcohol research and has created health prediction technologies using AI and machine learning. The Company has expertise in using speech analytics as a prediction tool for drug and alcohol intoxication and has created a voice and AI powered prediction model for drug and alcohol intoxication for use in consumer and enterprise situations. The Company is developing an enterprise platform using voice and powered by AI for use in detecting drug and alcohol intoxication in workplaces, law enforcement, mental health and telehealth.
Source: MindBio Therapeutics Corp.
Share this story:
